Blb&B Advisors, LLC Bristol Myers Squibb CO Transaction History
Blb&B Advisors, LLC
- $1.93 Billion
- Q4 2024
A detailed history of Blb&B Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blb&B Advisors, LLC holds 23,539 shares of BMY stock, worth $1.41 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
23,539
Previous 25,833
8.88%
Holding current value
$1.41 Million
Previous $1.34 Million
0.37%
% of portfolio
0.07%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,765Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.52 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.76 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.71 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.62 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...